Skip to main content
. 2020 Oct 7;11(10):832. doi: 10.1038/s41419-020-2584-z

Fig. 1. Expression and cellular localization of LL22NC03-N14H11.1 in HCC.

Fig. 1

a Differentially expressed lncRNAs in HCC samples from circlncRNAnet data (P < 0.05, Log 2 FC > 1) were compared to the data of differentially expressed genes and genes associated with survival in HCC samples from GEPIA2. Intersection of Venn pattern showed that three lncRNAs, LL22NC03-N14H11.1, LINC00152, and RP11-620J15.3 were sorted out. b RT-qPCR data of the levels of three above-mentioned lncRNAs in 62 pairs of HCC tissues and paired non-tumorous ones. c GEPIA data of LL22NC03-N14H11.1 upregulation in LIHC samples and the association of high LL22NC03-N14H11.1 level with low survival in LIHC patients. d RT-qPCR data of LL22NC03-N14H11.1 level in HCC tissues at stage I/II (N = 22) and stage III/IV (N = 40), and in non-metastasis HCC tissues (N = 31) and metastasis HCC tissues (N = 31). e RT-qPCR results of LL22NC03-N14H11.1 level in five HCC cell lines and normal cell line. f Prediction results of lncLocator indicated LL22NC03-N14H11.1 localization mainly in the nucleus. g Subcellular fractionation and FISH staining confirmed that LL22NC03-N14H11.1 was mainly localized in the nucleus in SK-HEP-1 cells. Scale bar: 25 μm. *P < 0.05; **P < 0.01.